What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Pre-registration for the 8th edition of the Master in Translational Biomedical Research of the VHIR The pre-registration period for the academic year 2021-2022 of the Master in Translational Biomedical Research of the VHIR will be open from January 11 to September 6 2021, or until the available places are exhausted. News One in four patients admitted to the ICU with COVID-19 suffers a thrombosis, which in many cases is asymptomatic The study, carried out with 230 patients at the ICUs of the Vall d'Hebron and Germans Trias i Pujol University Hospitals, is the world's largest published series of patients with COVID-19 and thrombosis in the ICU. News Vall d’Hebron includes the world’s first patient in Pfizer’s Phase 3 gene therapy clinical trial for Duchenne muscular dystrophy Vall d'Hebron became the first center in the world to include a patient (a 5-year-old boy) in the phase 3 gene therapy clinical trial for Duchenne muscular dystrophy. News Vall d’Hebron designs boxes with humanizing illustrations to cover the serums of pediatric patients The Superbox initiative aims to provide an innovative tool for pediatric patients so that they can live the medication experience more positively and increase their well-being. News Presentació del Nou Pla Estratègic Recerca Vall d’Hebron 2021-2025 El passat 2 de Desembre de 2020 es va aprovar el nou Pla Estratègic del VHIR 2021-2025 per part del Patronat del VHIR, on es defineixen les línies generals d'actuació de la recerca de Vall d'Hebron per tal d'afrontar els nous reptes i necessitats de futur dels propers anys. News The AECC Scientific Foundation provides a grant to Dr. Marco Inzitari for the study of cancer in the elderly. Dr. Marco Inzitari has been awarded a competitive grant for the study of cancer in the elderly, awarded by the Scientific Foundation of the Spanish Association Against Cancer (AECC). News Vall d'Hebron begins clinical trial of Janssen's Covid-19 vaccine This week Vall d'Hebron has started recruiting volunteers to participate in the phase III clinical trial of the Covid-19 vaccine from Janssen Pharmaceuticals (Johnson & Johnson). News Vall d'Hebron suggests that the immune system through a cytotoxic attack of T lymphocytes would cause Parkinson's disease This study may become a first step in definitively determining the cause of Parkinson's disease and in establishing new therapeutic targets to stop or even prevent the disease. News Two researchers at Vall d’Hebron awarded at the 2020 Multiple Sclerosis Solidarity Awards Dr. Manuel Comabella and Dr. Sunny Malhotra have been recognized by Fundación Merck Salud for their research on prognostic factors for multiple sclerosis. News Vall d’Hebron will study how virtual reality can improve the treatment of obesity The researchers will develop a virtual reality system that will allow obese patients to be aware of their body, overcome stigma, increase their self-esteem and help them cope with the lifestyle changes necessary to start losing weight. News Vall d’Hebron researchers publish a review on the influence of radiotherapy and cancer surgery on the immune system The work, published in Frontiers in Oncology, emphasizes the role of the tumor microenvironment in response to treatments. News New Vall d’Hebron research building work begins The building will have an area of 16,792 m2 dedicated to research and will house the latest technology in the field of advanced therapies. News The antitumor drug ABTL0812 shows promising results against neuroblastoma The study is led by the Translational Research Group in Cancer in Childhood and Adolescence of the Vall Hebron Research Institute (VHIR) and the biopharmaceutical company, AbilityPharma. News La Fundació ”la Caixa” atorga 1,5 milions d’euros a investigacions socials d'excel·lència L'entitat ha finançat un total de 15 projectes. News 14th Scientific Conference and 24th Vall d'Hebron Annual Conference The conference has included oral presentations of research and results of the VHIR, posters and scientific monologues. News A publication in which Vall d'Hebron participates points out the need to develop new drugs for childhood cancer The publication published in the journal Cancer Discovery highlights both the challenges and opportunities for the development of new drugs for the treatment of childhood cancer. News Vall d’Hebron participates in a study that suggests that patients with glomerular disease suffer a higher mortality from COVID-19 The VHIR has participated in a study that has revealed the effects of SARS-CoV-2 infection in people with glomerular disease, showing that they face a higher mortality and risk of suffering acute kidney injury. News Dr. Mar Hernández receives the Albus Award from Grifols for a project on albumin and Alzheimer's Every year, the Grifols Albus Program awards euros 50,000 to two innovative ideas on the possible therapeutic applications of albumin. News Un estudi prospectiu de Vall d’Hebron confirma que els menors d’edat són poc transmissors del SARS-CoV-2 Només un 8% (86 casos) dels pacients pediàtrics amb COVID-19 confirmat a Catalunya entre l'1 de juliol i el 31 d'octubre van transmetre la infecció causada pel SARS-CoV-2 dins del seu nucli familiar. News This Giving Tuesday, Vall d’Hebron encourages society to take part in the #SumaContraLaCovid campaign #GivingTuesday és un moviment global per incentivar la col.laboració en causes socials i multiplicar les bones accions de les persones. Vall d'Hebron és una de les entitats promotores d'aquesta iniciativa. Pagination First page « Previous page ‹ … Page 60 Page 61 Current page 62 Page 63 Page 64 … Next page › Last page »
